Cargando…
Epigenetic-Like Stimulation of Receptor Expression in SSTR2 Transfected HEK293 Cells as a New Therapeutic Strategy
SIMPLE SUMMARY: Neuroendocrine tumors (NETs) expressing the somatostatin receptor subtype 2 (SSTR2) are promising targets for peptide receptor radionuclide therapy (PRRT) using the somatostatin analogue Lu-177-DOTATATE. Patients expressing low levels of SSTR2 do not benefit from PRRT. Therefore, an...
Autores principales: | Kotzerke, Joerg, Buesser, Dorothee, Naumann, Anne, Runge, Roswitha, Huebinger, Lisa, Kliewer, Andrea, Freudenberg, Robert, Brogsitter, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140012/ https://www.ncbi.nlm.nih.gov/pubmed/35626117 http://dx.doi.org/10.3390/cancers14102513 |
Ejemplares similares
-
Up-Regulation of PSMA Expression In Vitro as Potential Application in Prostate Cancer Therapy
por: Runge, Roswitha, et al.
Publicado: (2023) -
Psoralen as a Photosensitizers for Photodynamic Therapy by Means of In Vitro Cherenkov Light
por: Hübinger, Lisa, et al.
Publicado: (2022) -
Predicting Transiently Expressed Protein Yields: Comparison of Transfection Methods in CHO and HEK293
por: Porosk, Ly, et al.
Publicado: (2022) -
Ac-EAZY! Towards GMP-Compliant Module Syntheses of (225)Ac-Labeled Peptides for Clinical Application
por: Pretze, Marc, et al.
Publicado: (2021) -
The calcium-sensing receptor regulates parathyroid hormone gene expression in transfected HEK293 cells
por: Galitzer, Hillel, et al.
Publicado: (2009)